How science will help shape future clinical applications of probiotics

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Gregor Reid

Abstract

The recent increased interest in probiotics among clinicians has many causes, primarily the concern about the limitations of the current armamentarium of pharmaceutical agents. Although probiotics have been used mostly in dietary supplements and foods to maintain health, scientific and clinical studies are recognizing the potential of some probiotics to be therapeutic in function. Scientific breakthroughs in understanding the source and composition of the human microbiota, the key nutritional factors that influence these microbes, and their immunomodulatory effects; the creation of disease-targeted recombinant strains; the isolation and characterization of signaling molecules that can modulate microbial biofilms and infectious processes; and advances in biomedical engineering that will provide new delivery systems for probiotics will shape the future of clinical applications of probiotics. In time and with rigorous documentation, some probiotics will likely find an important place in medical practice.

References

Nov 17, 1990·BMJ : British Medical Journal·D J Barker
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·L V HooperJ I Gordon
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M C Stiner
Jan 5, 2002·Applied and Environmental Microbiology·Christine F FavierAntoon D L Akkermans
Nov 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Thaddeus S StappenbeckJeffrey I Gordon
Jan 7, 2003·Applied and Environmental Microbiology·Jeremy P BurtonGregor Reid
Jan 16, 2003·Nucleic Acids Research·Veronika ZabarovskaEugene R Zabarovsky
Apr 12, 2003·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Dave H LeeOscar A Cruz
Jul 19, 2003·Journal of Clinical Gastroenterology·Gregor ReidTodd R Klaenhammer
Jan 7, 2004·Journal of Microbiological Methods·T ThurnheerB Guggenheim
Feb 1, 2005·Journal of Human Lactation : Official Journal of International Lactation Consultant Association·Rocío MartínJuan M Rodríguez
Oct 13, 2005·FEMS Microbiology Reviews·Erin K ShinerSimon C Williams
Nov 4, 2005·The New England Journal of Medicine·David N FredricksJeanne M Marrazzo
Nov 9, 2005·Environmental Health : a Global Access Science Source·Py TubeliusAnders Zachrisson
May 5, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·Francisco GuarnerGraham A W Rook
May 24, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Henri BraatLothar Steidler
Sep 26, 2006·Odontology·Jacob M ten Cate
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Jan 20, 2007·Colloids and Surfaces. B, Biointerfaces·Sheri SaundersGregor Reid

❮ Previous
Next ❯

Citations

Aug 5, 2010·Clinical Journal of Oncology Nursing·Karen L Visich, Theresa Pluth Yeo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Freddie Ann HoffmanPatricia L Hibberd
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Sebastian Fraune, Thomas C G Bosch
© 2021 Meta ULC. All rights reserved